CAPTRUST Financial Advisors
BCDA icon

CAPTRUST Financial Advisors’s BioCardia BCDA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-44,042
Closed -$958K – 2259
2022
Q2 		$958K Hold
44,042
– – 0.01% 854
2022
Q1 		$1.37M Hold
44,042
– – 0.01% 718
2021
Q4 		$1.28M Hold
44,042
– – 0.01% 703
2021
Q3 		$2.07M Buy
44,042
+84
+0.2% +$4.12K 0.02% 516
2021
Q2 		$2.62M Hold
43,958
– – 0.02% 430
2021
Q1 		$2.86M Hold
43,958
– – 0.03% 379
2020
Q4 		$2.28M Hold
43,958
– – 0.03% 378
2020
Q3 		$1.58M Buy
43,958
+13
+0% +$474 0.03% 385
2020
Q2 		$1.61M Buy
+43,945
New +$2.38M 0.03% 393

Other funds holding BCDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
FM
Family Management New York $834M AUM 20.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAPTRUST Financial Advisors's BCDA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of BioCardia (BCDA) in Q3 2022, closing a stake of 44,042 shares — an estimated $958K sold.

CAPTRUST Financial Advisors first reported a position in BCDA in Q2 2020 and held it in 9 quarters. The position peaked at $2.86M in Q1 2021. 23 funds tracked by Wall St. Rank hold BCDA as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining BioCardia position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 44,042 BioCardia shares in Q3 2022, an estimated $958K.
  • CAPTRUST Financial Advisors first reported a position in BioCardia in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's BioCardia position peaked at $2.86M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held BioCardia as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.